| |
 |
|
|
|
|
|
Poster: 273
Visits: 104
Title: Pixantrone has pre-clinical synergistic activity when combined with targeted agents in diffuse large B-cell lymphoma.
Authors: Chiara Tarantelli , Eugenio Gaudio, Ivo Kwee, Anastasios Stathis, Patrik Zintl, Emanuele Zucca, Francesco Bertoni
Centre: Institute of Oncology Research
|
|
You must be registered to reply or comment.
|
|
PIXANTRONE HAS PRE-CLINICAL SYNERGISTIC ACTIVITY WHEN COMBINED WITH TARGETED AGENTS IN DIFFUSE LARGE B-CELL LYMPHOMA.
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 274
Visits: 159
Title: Novel CD37-Targeting Antibody-Drug Conjugate (ADC), IMGN529, Has Synergistic Activity in Combination with Rituximab in Non-Hodgkin Lymphoma (NHL) Models
Authors: Angela Romanelli , JF Ponte, J Deckert, K OCallaghan, JA Coccia, L Lanieri, S Chicklas, R Ruiz-Soto
Centre: ImmunoGen Inc
|
|
|
|
